Arnab Ghosh, MD, PhD
Bone Marrow Transplant Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Stem Cell Transplantation
- Chimeric Antigen Receptor (CAR) T cell therapy and other Cell Therapies
- Lymphoma
Request an Appointment
About Me
- Assistant Attending Physician
I am a medical oncologist who specializes in hematopoietic stem cell transplantation and cell therapies for lymphomas. I am also a physician-scientist whose research focuses on understanding the biology of antitumor immunity (immune responses that support tumor control, increasing the efficacy of these therapies).
Read more
Previously, our studies have shown that chimeric antigen receptor (CAR) T cells from a donor can be used safely and without an increased risk of graft-versus-host disease (GVHD). GVHD is a complication that can occur after a stem cell or bone marrow transplant using donor cells. It happens when donor immune cells identify the host’s (the person getting the transplant) tissue as foreign and begin to attack it.
My recent research led to discovery of a novel mechanism by which p53, a protein often lost in cancers, can reprogram the microenvironment to help the immune system recognize it. This led to the development of a successful clinical trial of the p53-stablizing drug eprenetapopt with the PD-1-blocker pembrolizumab. The combination was tested in patients with solid tumors where treatment with one immune checkpoint blockade drug had failed.
My current research program focuses on understanding early immunological and molecular events after transplantation and other cell therapies. Our studies can help answer how can prevent or facilitate relapse of malignancies after these therapies.
As a medical oncologist and physician-scientist, my patient care philosophy is rooted in the use of scientific evidence. I use scientific evidence and an awareness of patients’ individual values and wishes to guide the clinical recommendations I make. This approach helps us to work in partnership, getting patients personalized, evidence-based care.
A bone marrow transplant specialist is a doctor with special training in bone marrow transplants.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Stem Cell Transplantation
- Chimeric Antigen Receptor (CAR) T cell therapy and other Cell Therapies
- Lymphoma
- Hematologic Malignancies
- Autologous Stem Cell Transplantation
- Immunotherapy
- Immune Reconstitution
Education
- MBBS, Mysore Medical College
- PhD, Medizinische Hochschule Hannover
Residencies
- Internal Medicine - Mount Sinai Hospital
Fellowships
- Medical Oncology and Hematology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
- Hematology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Ghosh sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Arnab Ghosh discloses the following relationships and financial interests:
-
Adivo Associates LLC
Professional Services and Activities -
Cancer Prevention & Research Institute of Texas
Professional Services and Activities -
Doximity, Inc.
Equity
-
Gerson Lehrman Group
Professional Services and Activities -
Guidepoint Global Advisors
Professional Services and Activities -
groupH Ltd
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
